Key result
A directed maturation protocol for human cardiac organoids enhanced cardiomyocyte maturation and enabled modeling of desmoplakin-related cardiomyopathy, identifying INCB054329 as a mitigating drug.
Why the study?
Maturation of human pluripotent stem cell-derived cardiomyocytes is critical for their use as a model system.
A directed maturation protocol using AMPK and ERR agonists significantly enhances the maturation of human cardiac organoids, enabling more accurate disease modeling and drug screening.
Answers are grounded in this paper and cite their sources.
May advance hPSC-CM maturation protocols for research models; leaves open in vivo or clinical translation.
Maturation of human pluripotent stem (hPS) cell-derived cardiomyocytes is critical for their use as a model system. Here we mimic human heart maturation pathways in the setting of hPS cell-derived cardiac organoids (hCOs). Specifically, transient activation of 5' AMP-activated protein kinase and estrogen-related receptor enhanced cardiomyocyte maturation, inducing expression of mature sarcomeric and oxidative phosphorylation proteins, and increasing metabolic capacity. hCOs generated using the directed maturation protocol (DM-hCOs) recapitulate cardiac drug responses and, when derived from calsequestrin 2 (CASQ2) and ryanodine receptor 2 (RYR2) mutant hPS cells exhibit a pro-arrhythmia phenotype. These DM-hCOs also comprise multiple cell types, which we characterize and benchmark to the human heart. Modeling of cardiomyopathy caused by a desmoplakin (DSP) mutation resulted in fibrosis and cardiac dysfunction and led to identifying the bromodomain and extra-terminal inhibitor INCB054329 as a drug mitigating the desmoplakin-related functional defect. These findings establish DM-hCOs as a versatile platform for applications in cardiac biology, disease and drug screening.
No takes yet. Share an insight, caveat, or question.
Pocock et al. (2025) studied Cardiomyopathy and pro-arrhythmia. Directed maturation protocol and INCB054329 was evaluated on Cardiomyocyte maturation and disease modeling. A directed maturation protocol for human cardiac organoids enhanced cardiomyocyte maturation and enabled modeling of desmoplakin-related cardiomyopathy, identifying INCB054329 as a mitigating drug.
Synapse has enriched 10 related papers. Consider them for comparative context: